ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,660,131 | -21.4% | 553,377 | -2.0% | 0.01% | -16.7% |
| Q2 2023 | $2,112,247 | -0.3% | 564,772 | -10.7% | 0.01% | -7.7% |
| Q1 2023 | $2,117,971 | -11.8% | 632,230 | +26.7% | 0.01% | -18.8% |
| Q4 2022 | $2,400,469 | +10.9% | 499,058 | +31.2% | 0.02% | -5.9% |
| Q3 2022 | $2,165,000 | -29.5% | 380,517 | -12.0% | 0.02% | -29.2% |
| Q2 2022 | $3,070,000 | +176.8% | 432,438 | +181.5% | 0.02% | +242.9% |
| Q1 2022 | $1,109,000 | – | 153,605 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |